Label
Search
SKIP TO CONTENT
SKIP NAVIGATION
Patient Resources
Clinical Trial Listings
What are Clinical Trials?
Become a Clinical Trial Volunteer
Useful Resources
FDA Approved Drugs
Professional Resources
Research Center Profiles
Market Research
Benchmark Reports
FDA Approved Drugs
Training Guides
Books
eLearning
Events
Newsletters
White Papers
SOPs
White Papers
Clinical Trial Listings
Advertise
Sign In
Create Account
Sign Out
My Account
Home
» Improving Minority Inclusion in Clinical Trials: Rethinking ‘Race’ and Other Variables to Improve Diversity
Looking to read the full article? Subscribe today!
Improving Minority Inclusion in Clinical Trials: Rethinking ‘Race’ and Other Variables to Improve Diversity
September 30, 2021
Sue Coons
The clinical research industry has made some progress toward improving diversity in clinical research, but the latest U.S. Census still shows minorities are underrepresented in trials.
Upcoming Events
23
Apr
Managing Data and Documentation for FDA Inspections and Remote Assessments
07
May
Effective Root Cause Analysis and CAPA Investigations for Drugs, Devices and Clinical Trials
14
May
2024 Avoca Quality Consortium Summit
Featured Products
Surviving an FDA GCP Inspection: Resources for Investigators, Sponsors, CROs and IRBs
Best Practices for Clinical Trial Site Management
Featured Stories
Thought Leadership: Remote Patient Monitoring Gives New View of Safety in Cardiac Clinical Trials
Ask the Experts: Applying Quality by Design to Protocols
Clinical Trials Need Greater Representation of Obese Patients, Experts Say
FDA IT Modernization Plan Prioritizes Data-Sharing, AI, Collaboration and More
Standard Operating Procedures for Risk-Based Monitoring of Clinical Trials
The information you need to adapt your monitoring plan to changing times.
Learn More Here